Recent genome-wide studies have identified a major asthma susceptibility locus near the IL-33 gene, correlating with disease severity [4]. In a mouse model, the deficiency of IL-33 has been shown to decrease allergen- or protease-induced type 2 airway inflammation [5]. The gene discussed is IL33; the disease is asthma.